| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7727552 | EISAI INC | Oral pharmaceutical preparations decreased in bitterness by masking |
Mar, 2018
(6 years ago) | |
| US7727548 | EISAI INC | Rapidly disintegrable tablet containing polyvinyl alcohol |
Jun, 2022
(1 year, 10 months ago) | |
Aricept Odt is owned by Eisai Inc.
Aricept Odt contains Donepezil Hydrochloride.
Aricept Odt has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Aricept Odt are:
- US7727552
- US7727548
Aricept Odt was authorised for market use on 18 October, 2004.
Aricept Odt is available in tablet, orally disintegrating;oral dosage forms.
Aricept Odt can be used as administration of approved product for treatment of alzheimer's disease.
The generics of Aricept Odt are possible to be released after 23 June, 2022.
Drugs and Companies using DONEPEZIL HYDROCHLORIDE ingredient
Market Authorisation Date: 18 October, 2004
Treatment: Administration of approved product for treatment of alzheimer's disease
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
ARICEPT ODT family patents
